
The global Oxymorphone Hydrochloride market size was valued at US$ 2349 million in 2024 and is forecast to a readjusted size of USD 5061 million by 2031 with a CAGR of 11.7% during review period.
It is a highly potent opioid analgesic indicated for treatment of severe pain
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Oxymorphone Hydrochloride market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Oxymorphone Hydrochloride market size and forecasts, in consumption value ($ Million), sales quantity (Box), and average selling prices (US$/Box), 2020-2031
Global Oxymorphone Hydrochloride market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Box), and average selling prices (US$/Box), 2020-2031
Global Oxymorphone Hydrochloride market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Box), and average selling prices (US$/Box), 2020-2031
Global Oxymorphone Hydrochloride market shares of main players, shipments in revenue ($ Million), sales quantity (Box), and ASP (US$/Box), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oxymorphone Hydrochloride
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oxymorphone Hydrochloride market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva, Ajanta Pharma, Aurobindo Pharma, Avanthi Pharma, Endo Pharm, Epic Pharma, Hikma Pharmaceuticals, Amneal Pharmaceutical, Mallinckrodt Pharmaceuticals, Par Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Oxymorphone Hydrochloride market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
 30Mg
 10Mg
 5Mg
 Other
麻豆原创 segment by Application
 Chronic Lymphocytic Leukemia
 Follicular Lymphoma
Major players covered
 Teva
 Ajanta Pharma
 Aurobindo Pharma
 Avanthi Pharma
 Endo Pharm
 Epic Pharma
 Hikma Pharmaceuticals
 Amneal Pharmaceutical
 Mallinckrodt Pharmaceuticals
 Par Pharmaceutical
 Sun Pharmaceutical
 Humanwell
 Aurolife Pharma LLC
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oxymorphone Hydrochloride product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oxymorphone Hydrochloride, with price, sales quantity, revenue, and global market share of Oxymorphone Hydrochloride from 2020 to 2025.
Chapter 3, the Oxymorphone Hydrochloride competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oxymorphone Hydrochloride breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Oxymorphone Hydrochloride market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oxymorphone Hydrochloride.
Chapter 14 and 15, to describe Oxymorphone Hydrochloride sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
 1.1 Product Overview and Scope
 1.2 麻豆原创 Estimation Caveats and Base Year
 1.3 麻豆原创 Analysis by Type
 1.3.1 Overview: Global Oxymorphone Hydrochloride Consumption Value by Type: 2020 Versus 2024 Versus 2031
 1.3.2 30Mg
 1.3.3 10Mg
 1.3.4 5Mg
 1.3.5 Other
 1.4 麻豆原创 Analysis by Application
 1.4.1 Overview: Global Oxymorphone Hydrochloride Consumption Value by Application: 2020 Versus 2024 Versus 2031
 1.4.2 Chronic Lymphocytic Leukemia
 1.4.3 Follicular Lymphoma
 1.5 Global Oxymorphone Hydrochloride 麻豆原创 Size & Forecast
 1.5.1 Global Oxymorphone Hydrochloride Consumption Value (2020 & 2024 & 2031)
 1.5.2 Global Oxymorphone Hydrochloride Sales Quantity (2020-2031)
 1.5.3 Global Oxymorphone Hydrochloride Average Price (2020-2031)
2 Manufacturers Profiles
 2.1 Teva
 2.1.1 Teva Details
 2.1.2 Teva Major Business
 2.1.3 Teva Oxymorphone Hydrochloride Product and Services
 2.1.4 Teva Oxymorphone Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
 2.1.5 Teva Recent Developments/Updates
 2.2 Ajanta Pharma
 2.2.1 Ajanta Pharma Details
 2.2.2 Ajanta Pharma Major Business
 2.2.3 Ajanta Pharma Oxymorphone Hydrochloride Product and Services
 2.2.4 Ajanta Pharma Oxymorphone Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
 2.2.5 Ajanta Pharma Recent Developments/Updates
 2.3 Aurobindo Pharma
 2.3.1 Aurobindo Pharma Details
 2.3.2 Aurobindo Pharma Major Business
 2.3.3 Aurobindo Pharma Oxymorphone Hydrochloride Product and Services
 2.3.4 Aurobindo Pharma Oxymorphone Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
 2.3.5 Aurobindo Pharma Recent Developments/Updates
 2.4 Avanthi Pharma
 2.4.1 Avanthi Pharma Details
 2.4.2 Avanthi Pharma Major Business
 2.4.3 Avanthi Pharma Oxymorphone Hydrochloride Product and Services
 2.4.4 Avanthi Pharma Oxymorphone Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
 2.4.5 Avanthi Pharma Recent Developments/Updates
 2.5 Endo Pharm
 2.5.1 Endo Pharm Details
 2.5.2 Endo Pharm Major Business
 2.5.3 Endo Pharm Oxymorphone Hydrochloride Product and Services
 2.5.4 Endo Pharm Oxymorphone Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
 2.5.5 Endo Pharm Recent Developments/Updates
 2.6 Epic Pharma
 2.6.1 Epic Pharma Details
 2.6.2 Epic Pharma Major Business
 2.6.3 Epic Pharma Oxymorphone Hydrochloride Product and Services
 2.6.4 Epic Pharma Oxymorphone Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
 2.6.5 Epic Pharma Recent Developments/Updates
 2.7 Hikma Pharmaceuticals
 2.7.1 Hikma Pharmaceuticals Details
 2.7.2 Hikma Pharmaceuticals Major Business
 2.7.3 Hikma Pharmaceuticals Oxymorphone Hydrochloride Product and Services
 2.7.4 Hikma Pharmaceuticals Oxymorphone Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
 2.7.5 Hikma Pharmaceuticals Recent Developments/Updates
 2.8 Amneal Pharmaceutical
 2.8.1 Amneal Pharmaceutical Details
 2.8.2 Amneal Pharmaceutical Major Business
 2.8.3 Amneal Pharmaceutical Oxymorphone Hydrochloride Product and Services
 2.8.4 Amneal Pharmaceutical Oxymorphone Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
 2.8.5 Amneal Pharmaceutical Recent Developments/Updates
 2.9 Mallinckrodt Pharmaceuticals
 2.9.1 Mallinckrodt Pharmaceuticals Details
 2.9.2 Mallinckrodt Pharmaceuticals Major Business
 2.9.3 Mallinckrodt Pharmaceuticals Oxymorphone Hydrochloride Product and Services
 2.9.4 Mallinckrodt Pharmaceuticals Oxymorphone Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
 2.9.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
 2.10 Par Pharmaceutical
 2.10.1 Par Pharmaceutical Details
 2.10.2 Par Pharmaceutical Major Business
 2.10.3 Par Pharmaceutical Oxymorphone Hydrochloride Product and Services
 2.10.4 Par Pharmaceutical Oxymorphone Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
 2.10.5 Par Pharmaceutical Recent Developments/Updates
 2.11 Sun Pharmaceutical
 2.11.1 Sun Pharmaceutical Details
 2.11.2 Sun Pharmaceutical Major Business
 2.11.3 Sun Pharmaceutical Oxymorphone Hydrochloride Product and Services
 2.11.4 Sun Pharmaceutical Oxymorphone Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
 2.11.5 Sun Pharmaceutical Recent Developments/Updates
 2.12 Humanwell
 2.12.1 Humanwell Details
 2.12.2 Humanwell Major Business
 2.12.3 Humanwell Oxymorphone Hydrochloride Product and Services
 2.12.4 Humanwell Oxymorphone Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
 2.12.5 Humanwell Recent Developments/Updates
 2.13 Aurolife Pharma LLC
 2.13.1 Aurolife Pharma LLC Details
 2.13.2 Aurolife Pharma LLC Major Business
 2.13.3 Aurolife Pharma LLC Oxymorphone Hydrochloride Product and Services
 2.13.4 Aurolife Pharma LLC Oxymorphone Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
 2.13.5 Aurolife Pharma LLC Recent Developments/Updates
3 Competitive Environment: Oxymorphone Hydrochloride by Manufacturer
 3.1 Global Oxymorphone Hydrochloride Sales Quantity by Manufacturer (2020-2025)
 3.2 Global Oxymorphone Hydrochloride Revenue by Manufacturer (2020-2025)
 3.3 Global Oxymorphone Hydrochloride Average Price by Manufacturer (2020-2025)
 3.4 麻豆原创 Share Analysis (2024)
 3.4.1 Producer Shipments of Oxymorphone Hydrochloride by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
 3.4.2 Top 3 Oxymorphone Hydrochloride Manufacturer 麻豆原创 Share in 2024
 3.4.3 Top 6 Oxymorphone Hydrochloride Manufacturer 麻豆原创 Share in 2024
 3.5 Oxymorphone Hydrochloride 麻豆原创: Overall Company Footprint Analysis
 3.5.1 Oxymorphone Hydrochloride 麻豆原创: Region Footprint
 3.5.2 Oxymorphone Hydrochloride 麻豆原创: Company Product Type Footprint
 3.5.3 Oxymorphone Hydrochloride 麻豆原创: Company Product Application Footprint
 3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
 4.1 Global Oxymorphone Hydrochloride 麻豆原创 Size by Region
 4.1.1 Global Oxymorphone Hydrochloride Sales Quantity by Region (2020-2031)
 4.1.2 Global Oxymorphone Hydrochloride Consumption Value by Region (2020-2031)
 4.1.3 Global Oxymorphone Hydrochloride Average Price by Region (2020-2031)
 4.2 North America Oxymorphone Hydrochloride Consumption Value (2020-2031)
 4.3 Europe Oxymorphone Hydrochloride Consumption Value (2020-2031)
 4.4 Asia-Pacific Oxymorphone Hydrochloride Consumption Value (2020-2031)
 4.5 South America Oxymorphone Hydrochloride Consumption Value (2020-2031)
 4.6 Middle East & Africa Oxymorphone Hydrochloride Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
 5.1 Global Oxymorphone Hydrochloride Sales Quantity by Type (2020-2031)
 5.2 Global Oxymorphone Hydrochloride Consumption Value by Type (2020-2031)
 5.3 Global Oxymorphone Hydrochloride Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
 6.1 Global Oxymorphone Hydrochloride Sales Quantity by Application (2020-2031)
 6.2 Global Oxymorphone Hydrochloride Consumption Value by Application (2020-2031)
 6.3 Global Oxymorphone Hydrochloride Average Price by Application (2020-2031)
7 North America
 7.1 North America Oxymorphone Hydrochloride Sales Quantity by Type (2020-2031)
 7.2 North America Oxymorphone Hydrochloride Sales Quantity by Application (2020-2031)
 7.3 North America Oxymorphone Hydrochloride 麻豆原创 Size by Country
 7.3.1 North America Oxymorphone Hydrochloride Sales Quantity by Country (2020-2031)
 7.3.2 North America Oxymorphone Hydrochloride Consumption Value by Country (2020-2031)
 7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
 7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
 7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
 8.1 Europe Oxymorphone Hydrochloride Sales Quantity by Type (2020-2031)
 8.2 Europe Oxymorphone Hydrochloride Sales Quantity by Application (2020-2031)
 8.3 Europe Oxymorphone Hydrochloride 麻豆原创 Size by Country
 8.3.1 Europe Oxymorphone Hydrochloride Sales Quantity by Country (2020-2031)
 8.3.2 Europe Oxymorphone Hydrochloride Consumption Value by Country (2020-2031)
 8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
 8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
 8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
 8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
 8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
 9.1 Asia-Pacific Oxymorphone Hydrochloride Sales Quantity by Type (2020-2031)
 9.2 Asia-Pacific Oxymorphone Hydrochloride Sales Quantity by Application (2020-2031)
 9.3 Asia-Pacific Oxymorphone Hydrochloride 麻豆原创 Size by Region
 9.3.1 Asia-Pacific Oxymorphone Hydrochloride Sales Quantity by Region (2020-2031)
 9.3.2 Asia-Pacific Oxymorphone Hydrochloride Consumption Value by Region (2020-2031)
 9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
 9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
 9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
 9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
 9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
 9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
 10.1 South America Oxymorphone Hydrochloride Sales Quantity by Type (2020-2031)
 10.2 South America Oxymorphone Hydrochloride Sales Quantity by Application (2020-2031)
 10.3 South America Oxymorphone Hydrochloride 麻豆原创 Size by Country
 10.3.1 South America Oxymorphone Hydrochloride Sales Quantity by Country (2020-2031)
 10.3.2 South America Oxymorphone Hydrochloride Consumption Value by Country (2020-2031)
 10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
 10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
 11.1 Middle East & Africa Oxymorphone Hydrochloride Sales Quantity by Type (2020-2031)
 11.2 Middle East & Africa Oxymorphone Hydrochloride Sales Quantity by Application (2020-2031)
 11.3 Middle East & Africa Oxymorphone Hydrochloride 麻豆原创 Size by Country
 11.3.1 Middle East & Africa Oxymorphone Hydrochloride Sales Quantity by Country (2020-2031)
 11.3.2 Middle East & Africa Oxymorphone Hydrochloride Consumption Value by Country (2020-2031)
 11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
 11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
 11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
 11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
 12.1 Oxymorphone Hydrochloride 麻豆原创 Drivers
 12.2 Oxymorphone Hydrochloride 麻豆原创 Restraints
 12.3 Oxymorphone Hydrochloride Trends Analysis
 12.4 Porters Five Forces Analysis
 12.4.1 Threat of New Entrants
 12.4.2 Bargaining Power of Suppliers
 12.4.3 Bargaining Power of Buyers
 12.4.4 Threat of Substitutes
 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
 13.1 Raw Material of Oxymorphone Hydrochloride and Key Manufacturers
 13.2 Manufacturing Costs Percentage of Oxymorphone Hydrochloride
 13.3 Oxymorphone Hydrochloride Production Process
 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
 14.1 Sales Channel
 14.1.1 Direct to End-User
 14.1.2 Distributors
 14.2 Oxymorphone Hydrochloride Typical Distributors
 14.3 Oxymorphone Hydrochloride Typical Customers
15 Research Findings and Conclusion
16 Appendix
 16.1 Methodology
 16.2 Research Process and Data Source
 16.3 Disclaimer
Teva
Ajanta Pharma
Aurobindo Pharma
Avanthi Pharma
Endo Pharm
Epic Pharma
Hikma Pharmaceuticals
Amneal Pharmaceutical
Mallinckrodt Pharmaceuticals
Par Pharmaceutical
Sun Pharmaceutical
Humanwell
Aurolife Pharma LLC
听
听
*If Applicable.
